HealthyDirect · GrowthFit for a long SIP
Baroda BNP Paribas Large and Mid Cap fund
Baroda BNP Paribas Mutual FundEquity Scheme - Large & Mid Cap Fund6.2 years
The scheme seeks long term capital growth through investments in both large cap and mid cap stocks.
- NAV
- 30.092
- 5 Nov 2026
- 1Y
- +1.2%
- Trailing CAGR
- AUM
- ₹1,762.37 Cr
- 30 Sept 2026
- Volatility
- Medium
- 14.9% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 5 Nov 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 81% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Pass
6.2 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.09% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -20.6%. Ask whether you can hold through a similar fall.
Vs category
Pass
81% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Jitendra Sriram · 0.4 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 31.9% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 21%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+1.2%
- 3Y+15.2%
- 5Y+11.8%
- 10Yn/a
- SI+19.6%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+6.1%
- 3Y+6.3%
- 5Y+12.2%
- 10Yn/a
- Since inception
- +19.6%
- Calendar-day CAGR
- Excess 1Y
- +0.4%
- Category median, same plan and option
- 3Y win rate
- +81%
- Windows beating the median
- 3Y percentile
- 82
- Vs comparable share classes
- SIP 3Y XIRR
- +6.3%
- Simulated monthly SIP
- Worst rolling 3Y
- +12.2%
- 775 daily-ending windows
- Median rolling 3Y
- +20.1%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 284 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -20.6%
- Worst peak-to-trough
- Current
- -2.5%
- Below last peak
- Current spell
- 773 days
- Days below latest peak
- Time below peak
- +85%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 10 days
- 67 recovered episodes
- Longest recovery
- 350 days
- Trough to prior peak
18 Oct 2021 – 5 Jun 2023
Trough 20 Jun 2022 · recovered in 350 days
-20.6%
23 Sept 2024 – open
Trough 28 Feb 2025 · not recovered
-19.5%
3 Jun 2024 – 12 Jun 2024
Trough 4 Jun 2024 · recovered in 8 days
-7.3%
11 Sept 2023 – 17 Nov 2023
Trough 26 Oct 2023 · recovered in 22 days
-6.9%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
82
Vs category
53
Consistency
65
Risk-adjusted
70
Drawdown
49
Mean
64
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 81% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 54 holdings · top 10 are 31.9%.
- Top 5
- 18.7%
- Top 10
- 31.9%
- Largest holding
- 6.0%
- Effective holdings
- 43.3
Others CBLO
Unspecified
6.0%
One 97 Communications Ltd
Industrials
3.4%
The Federal Bank Ltd
Financial
3.2%
Radico Khaitan Ltd
Consumer Staples
3.1%
Bharat Heavy Electricals Ltd
Industrials
2.8%
What changed
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Motilal Oswal Large and Midcap Fund
Motilal Oswal Mutual Fund
- 1Y
- +6.3%
- 3Y
- +22.2%
- Vol
- 19.4%
- Max DD
- -37.4%
- Sharpe
- 0.82
- 3Y win
- +98%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
PGIM India Large and Midcap Fund
PGIM India Mutual Fund
- 1Y
- +2.6%
- 3Y
- n/a
- Vol
- 14.1%
- Max DD
- -15.5%
- Sharpe
- 0.39
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
Edelweiss Large & Mid Cap Fund
Edelweiss Mutual Fund
- 1Y
- +2.8%
- 3Y
- +14.9%
- Vol
- 15.7%
- Max DD
- -34.9%
- Sharpe
- 0.70
- 3Y win
- +88%
- Higher win rate vs category
- Lower TER
Caveat: Higher volatility · Deeper drawdown · Lower trailing returns
ITI Large & Mid Cap Fund
ITI Mutual Fund
- 1Y
- +2.1%
- 3Y
- n/a
- Vol
- 17.2%
- Max DD
- -20.2%
- Sharpe
- -0.20
- 3Y win
- n/a
- Shallower drawdown
- Lower TER
Caveat: Higher volatility · Lower trailing returns
Bandhan Large & Mid Cap Fund
Bandhan Mutual Fund
- 1Y
- +1.2%
- 3Y
- +18.0%
- Vol
- 15.8%
- Max DD
- -38.5%
- Sharpe
- 0.63
- 3Y win
- +61%
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER